Show simple item record

dc.contributor.authorEzequiel J. Zaidel
dc.contributor.authorSol C. Song
dc.contributor.authorJuan J. Sterba
dc.contributor.authorAgustina Piccinato
dc.contributor.authorMaría Candelaria Ramos
dc.contributor.authorSilvina L. Cacia
dc.date.accessioned2024-11-12T18:03:47Z
dc.date.available2025-10-02T03:38:38Z
dc.date.issued01-11-2024
dc.identifier.issn-
dc.identifier.urihttps://doi.org/10.1177/17539447241295957
dc.description.abstractAwareness, proper diagnosis and treatment of cardiac amyloidosis have increased, but there are still several unmet needs that have to be addressed for the optimal care of the disease. In this comprehensive review, we describe current and future treatments for both hereditary and wild-type TTR cardiac amyloidosis and also review lifestyle, including current challenges and opportunities for specific dietary concerns and exercise sports for these patients.
dc.format-
dc.language.isoEN
dc.publisherSAGE Publishing
dc.relation.uri['https://ascopubs.org/oa/about', 'https://ascopubs.org/authors/open-access', 'https://ascopubs.org/authors', 'https://ascopubs.org/journal/oa']
dc.rights['CC BY', 'CC BY-NC-ND']
dc.subject['oncology', 'global health', 'cancer research', 'clinical medicine', 'cancer', 'public health', 'Neoplasms. Tumors. Oncology. Including cancer and carcinogens', 'RC254-282']
dc.subject.lccDiseases of the circulatory (Cardiovascular) system
dc.titleWhat’s new in cardiac amyloidosis? Pharmacological treatment, physical activity, and care of patients with transthyretin cardiac amyloidosis
dc.typeArticle
dc.description.pages-
dc.description.doi10.1177/17539447241295957
dc.title.journalTherapeutic Advances in Cardiovascular Disease
dc.identifier.e-issn1753-9455
dc.identifier.oaioai:doaj.org/journal:b0800ad16e6c4438a90da2b553d024d8
dc.journal.info-


This item appears in the following Collection(s)

Show simple item record